Perrigo (PRGO) Confirms Patent Challenge for Generic Version of Nascobal

March 5, 2019 8:53 AM EST Send to a Friend
Perrigo Company plc (NYSE: PRGO) today announced that Endo Pharmaceuticals Inc. initiated patent litigation on March 1, 2019 in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login